Preface |
|
v | |
|
Quantitation in PET and image processing |
|
|
1 | (110) |
|
|
|
Role of human and animal PET studies in drug development |
|
|
3 | (9) |
|
|
Kinetic analysis of neuroreceptor binding using PET |
|
|
12 | (13) |
|
|
|
|
|
|
|
|
|
Formation of parametric images with statistical clustering |
|
|
25 | (6) |
|
|
Development of motion correction technique for PET study using optical tracking system |
|
|
31 | (8) |
|
|
|
|
|
|
3D deformable image processing and integration |
|
|
39 | (10) |
|
|
|
Impact of inter-subject image registration on group analysis of fMRI data |
|
|
49 | (11) |
|
|
|
|
|
|
Rapid protocol for quantitative CMRO2 and CBF using PET and O-15 labelled compounds |
|
|
60 | (9) |
|
|
|
|
|
|
|
|
|
|
|
Performance evaluation of microPET P4 for rat, rabbit and monkey |
|
|
69 | (5) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Simultaneous quantification of two brain functions with dual tracer injection in PET dynamic study |
|
|
74 | (5) |
|
|
|
|
Improved parametric images of blood flow and vascular volume by cluster analysis in H215O brain PET study |
|
|
79 | (5) |
|
|
|
|
|
|
Impact of image-based scatter correction for 123IMP-SPECT and SPM analysis |
|
|
84 | (5) |
|
|
|
|
|
|
|
|
|
Development of FDG-PET quantitative procedures without blood sampling |
|
|
89 | (4) |
|
|
|
|
|
New method for the synthesis of 15O-labeled carbon monoxide and 15O-labeled dioxide for rapid supply in clinical use |
|
|
93 | (4) |
|
|
|
|
|
Neutron reduction of the small cyclotron for production of oxygen-15-labeled gases |
|
|
97 | (4) |
|
|
|
|
|
|
Image improvement in pinhole SPECT using complete data acquisition combined with statistical image reconstruction |
|
|
101 | (5) |
|
|
|
|
|
|
|
|
|
|
Effects of motion correction on quantification of myocardial blood flow with 15O-H2O PET |
|
|
106 | (5) |
|
|
|
|
|
|
|
|
Quantitation and hyperpolarized contrast agent in MRI |
|
|
111 | (76) |
|
|
|
Quantitative T1 mapping and absolute water content measurement using MRI |
|
|
113 | (11) |
|
|
|
|
|
|
Hyperpolarized 129Xe as a novel probe agent of lung functions in MRI and MRS. Experimental results with mice at 9.4 T |
|
|
124 | (7) |
|
|
|
|
Dynamic spectroscopy of hyperpolarized Xe-129 in rat lung |
|
|
131 | (8) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In vivo MR spectroscopy of hyperpolarized Xe-129 in rat brain |
|
|
139 | (5) |
|
|
|
|
|
Developments of apparatus for hyperpolarization of Xe-129: optimized structure of cell for efficient spin exchange at a high concentration of optically pumped rubidium |
|
|
144 | (6) |
|
|
|
|
|
|
Measurement of cerebral blood flow with dynamic susceptibility contrast MRI and comparison with O-15 positron emission tomography |
|
|
150 | (9) |
|
|
|
|
|
|
|
Measurement of cerebral circulation by dynamic susceptibility contrast-enhanced MRI: effect of tracer delay |
|
|
159 | (8) |
|
|
|
|
|
|
|
|
|
|
MRI and MRS of mouse head at 9.4 T using hyperpolarized Xenon gas |
|
|
167 | (5) |
|
|
|
|
|
|
Practical application of NMR spectra of 129Xe dissolved in red blood cell |
|
|
172 | (5) |
|
|
|
|
|
|
MRS of hyperpolarized 129BXe in the chest of mouse---effect of contrast agents on the MRS |
|
|
177 | (4) |
|
|
|
|
|
Distortion correction in echo-planar imaging and quantitative T2* mapping |
|
|
181 | (6) |
|
|
|
|
Application of quantitative PET and MRI techniques |
|
|
187 | (94) |
|
|
|
Quantitative PET for assessment of cerebral blood flow and glucose consumption under varying physiological conditions |
|
|
189 | (12) |
|
|
|
|
Cortical layer-dependent CBF changes induced by neural activity |
|
|
201 | (10) |
|
|
|
|
|
Changes in CBF and CBV during changes in neural activity or PaCO2 measured by PET |
|
|
211 | (7) |
|
|
|
|
|
Measurement of arterial part of vascular volume (V0) for the evaluation of hemodynamic changes in cerebrovascular disease |
|
|
218 | (10) |
|
|
|
|
A physiological model for cerebral oxygen delivery and consumption and effective oxygen diffusibility evaluated by PET |
|
|
228 | (10) |
|
|
|
|
|
|
|
|
Cerebral perfusion measurements using continuous arterial spin labeling: accuracy and limits of a quantitative approach |
|
|
238 | (10) |
|
|
|
|
|
Positron emission tomography---molecular imaging of biological processes |
|
|
248 | (7) |
|
|
|
|
[ 18F]FDG mouse brain PET imaging: absolute quantification of regional cerebral glucose utilization as compared with 2-[ 14C]DG autoradiography |
|
|
255 | (7) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Development of injectable O-15 oxygen and its application for estimation of OEF |
|
|
262 | (4) |
|
|
|
|
|
|
|
|
|
|
|
Imaging of vulnerable atherosclerotic plaque with [ 18F]FDG-PET: an animal atherosclerosis model study |
|
|
266 | (3) |
|
|
|
|
|
|
|
|
|
|
|
Development of modified method for quantification of regional myocardial blood flow using 15O-water with PET |
|
|
269 | (6) |
|
|
|
|
|
Assessment of the precision in co-registration of structural MR images and PET images with localized binding |
|
|
275 | (6) |
|
|
|
|
|
|
|
Author index |
|
281 | (4) |
Keyword index |
|
285 | |